Evidence map›Paper›PMID 35979577›Full record

ArticleJournal of clinical and experimental hematopathology : JCEH2022

Surface CD3-negative monomorphic epitheliotropic intestinal T-cell lymphoma.

Hideharu Domoto, Takahiro Araki, Asuka Ogai, Michiko Inukai, Chien K Chen, Sakura Tomita, Kiyoshi Mukai, Naoya Nakamura

Open access · goldAbstract readCase Reports
In one paragraph

Article in Journal of clinical and experimental hematopathology : JCEH, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Hideharu DomotoDepartment of Diagnostic Pathology, Keiyu Hospital, Yokohama, Kanagawa, Japan.
Takahiro ArakiDepartment of Hematology, Keiyu Hospital, Yokohama, Kanagawa, Japan.
Asuka OgaiDepartment of Hematology, Keiyu Hospital, Yokohama, Kanagawa, Japan.
Michiko InukaiDepartment of Surgery, Keiyu Hospital, Yokohama, Kanagawa, Japan.
Chien K ChenDepartment of Hematology, Keiyu Hospital, Yokohama, Kanagawa, Japan.
Sakura TomitaDepartment of Pathological Diagnostics, Tokai University School of Medicine, Isehara, Kanagawa, Japan.
Kiyoshi MukaiDepartment of Diagnostic Pathology, Keiyu Hospital, Yokohama, Kanagawa, Japan.
Naoya NakamuraDepartment of Pathological Diagnostics, Tokai University School of Medicine, Isehara, Kanagawa, Japan.
keiyu Hospital · JPTokai University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Intestinal T/NK-cell lymphomas include enteropathy-associated T-cell lymphoma (EATL), monomorphic epitheliotropic intestinal T-cell lymphoma (MEITL), indolent T-cell lymphoproliferative disorders of the GI tract (ITCLPD), extranodal NK/T-cell lymphoma, nasal type (ENKTL), and intestinal T-cell lymphoma NOS (ITCL-NOS). Here we describe a case of surface CD3-negative MEITL. A 63-year-old Japanese female had a tumor located in the conglomerated ileum, which formed multiple mass lesions. The resected tissue showed a diffuse infiltration of monomorphic medium-sized lymphocytes with epitheliotropism. Flowcytometry using a fresh specimen of the tumor revealed positivity for CD7, CD8, CD38, and CD56, but not surface CD3. On immunohistochemistry, the tumor showed positivity for cytoplasmic CD3, CD8, CD56, TIA-1, Granzyme B, and perforin. EBER with in situ hybridization was negative. Moreover, H3K36me3, which is negative in MEITL with SETD2-mutation, was positive. This is an important case of MEITL due to its oncogenesis.

Indexed as

Enteropathy-Associated T-Cell LymphomaLymphoma, Extranodal NK-T-CellFemaleGranzymesHumansImmunohistochemistryMiddle AgedPerforinGranzymesPerforinflowcytometryintestinal T/NK-cell lymphomamonomorphic epitheliotropic intestinal T-cell lymphomasurface CD3

Identifiers

PMID35979577
PMCPMC9635036
OpenAlexW4292340136

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.